Abstract
OBJECTIVE: To determine the efficacy of the transdermal nicotine patch for smoking cessation in inner-city African Americans.
DESIGN: Double-blind, placebo-controlled, randomized trial.
SETTING: Outpatient in an inner-city hospital.
PATIENTS AND PARTICIPANTS: A computer-generated random numbers table with a block size set at 20 was used to randomize 410 patients to one of two study arms.
INTERVENTIONS: The transdermal nicotine patch for 10 weeks as an adjunct to brief counseling.
MEASUREMENTS AND MAIN RESULTS: Of the 410 patients randomized, mean age was 48 years, 65% were female, 41% had less than a high school education, 51% had an annual household income of less than $8,000, and the average number of cigarettes smoked per day was 20. Quit rates at 10 weeks were 21.5% (44/205) with the nicotine patch, and 13.7% (28/205) with the placebo patch (p=.03). At 6 months, quit rates were 17.1% (35/205) with the nicotine patch, and 11.7% (24/205) with the placebo patch (p=.08). After adjusting for baseline differences in age and educational attainment, differences remained significant at 10 weeks (p=.04), but were not significant at 6 months (p=.14). Compliance rates for return visits were 83%, 78%, 55%, and 52%, at 1, 2, 6, and 10 weeks, respectively.
CONCLUSIONS: The nicotine patch significantly improves short-term quit rates in inner-city African Americans who are interested in trying to quit smoking. Efforts should be made to reach underserved populations through smoking cessation programs, and to assist in maintaining abstinence.
Similar content being viewed by others
References
McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA. 1993;270:2207–12.
Centers for Disease Control. Cigarette smoking among adults—United States, 1993. MMWR. 1994;43:925–30.
Center for Disease Control. African Americans and smoking. Centers for Disease Control—At A Glance.
Givino GA, Henningfield JE, Tomar SL, Escobedo LG, Slade J. Epidemiology of tobacco use and dependence. Epidemiol Rev. 1995;17:48–65.
Hahn LP, Folsom AR, Sprafka JM, Norsted SW. Cigarette smoking and cessation behaviors among urban blacks and whites. Public Health Rep. 1990;105:290–5.
Ahluwalia JS, McNagny SE. Smoking prevalence and desire to quit in inner-city African-American walk-in clinic patients. Clin Res. 1993;41:752A.
Resnicow K, Futterman R, Weston RW, et al. Smoking prevalence of Harlem residents: baseline results from the Harlem Health Connection Project. Am J Health Promot. 1996;10:343–6.
Office on Smoking and Health. Adult Use of Tobacco. Washington, DC: U.S. Dept. of Health and Human Services, Public Health Service; 1989: PHS publication 90-2004.
U.S. Dept. of Health and Human Services. Reducing the Health Consequences of Smoking: 25 years of Progress. A Report of the Surgeon General. Washington, DC: U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1989. DHHS publication (CDC) 89-8411.
U.S. Dept. Health and Human Services. The Health Benefits of Smoking Cessation. U.S. Dept. Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1990. DHHS publication (CDC) 90–8416.
Martin R, Commings SR, Coates TJ. Ethnicity and smoking: differences in white, black, Hispanic and Asian. AM J Prev Med. 1990;6:194–9.
Novotny TE, Warner KE, Kendrick JS, Remington PL. Smoking by blacks and whites: socioeconomic and demographic differences. Am J Public Health. 1988;78:1187–9.
Centers for Disease Control. Smoking cessation during previous year among adults—United States, 1990 and 1991. MMWR. 1993;42:504–7.
Fiscella K, Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physician’s smoking cessation counseling. JAMA. 1996;275:1247–51.
Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation. JAMA. 1994;27:1940–7.
Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet. 1994;343:139–42.
Tang JL, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? BMJ. 1994;308:21–6.
Wasley MA, McNagny SE, Ahluwalia JS, Phillips VL. The cost-effectiveness of the nicotine transdermal patch for smoking cessation. Prev Med. 1997;26:264–70.
Fiore MC, Bailey WC, Cohen SJ, et al. Smoking Cessation: Iformation for Specialists. Clinical Practice Guideline. Quick Reference Guide for Smoking Cessation Specialists, No. 18. Rockvill, Md: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Centers for Disease Control and Prevention; 1996.
Williams MV, Parker RM, Baker DW, et al. Inadequate functional health literacy among patients at two public hospitals. JAMA. 1995;274:1677–82.
Gorsline J, Gupta SK, Dye D, Rolf CN. Nicotine dose relationship for Nicoderm (nicotine transdermal system) at steady state. Pharmacol Res. 1991;10 (suppl):S299.
Robinson RG, Orleans CT, James DA, Sutton CD. Pathways to Freedom: Winning the Fight Against Tobacco. Philadelphia, Pa: Fox Chase Center; 1992.
Marion Merrill Dow Inc. The 6-2-2 Committed Quitter’s Program: Nicoderm (Nicotine Transdermal System). Kansas City, Mo: Marion Merrill Dow Inc.; 1993.
Duelberg SI. Preventive health behavior among black and white women in urban and rural areas. Soc Sci Med. 1992:34:191–8.
Orleans CT, Schoenbach VJ, Salmon MA, et al. A survey of smoking and quitting patterns among black Americans. Am J Public Health. 1989;79:176–81.
Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989;12:159–82.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119–27.
Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley and Sons; 1989.
Abelin T, Ehrsam R, Buhler-Reichert A, Imhof PR, Muller P, Thommen A. Effectiveness of a transdermal nicotine system in smoking cessation studies. Methods Find Exp Clin Pharmacol. 1989;11:205–14.
Fiore MC, Kenford SL, Jorenby DE, Wetter DW, Smith SS, Baker TB. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Chest. 1994;105:524–33.
Richmond RL, Harris K, Neto A. The transdermal nicotine patch: results of a randomised placebo-controlled trial. Med J Aust. 1994;161:130–5.
Tonnesen P, Norregaard J, Simonsen K, Sawa U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med. 1991;325:311–5.
Romano PS, Bloom J, Syme SL. Smoking, social support, and hassles in an urban African-American community. Am J Public Health. 1991;81:1415–22.
Delongis A, Coyne J, Dakof G, Folkman S, Lazarus R. Relationship of daily hassles, uplifts, and major life events to health status. Health Psychol. 1982;1:119–36.
Robinson RG, Pertschuk JD, Sutton C. Smoking and African Americans. In: Samuels SE, Smith MD, eds. Improving the Health of the Poor—Strategies for Prevention. Menlo Park, Calif: The Henry J. Kaiser Family Foundation; 1992.
Short PF, Cornelius LJ, Goldstone DE. Health insurance of minorities in the United States. J Health Care Poor Underserved. 1990;1:9–24.
National Cancer Institute. Cancer Prevention Awareness Survey Wave II: Management Summary. Bethesda, Md: Office of Cancer Communications, National Cancer Institute, National Institutes of Health; 1987.
Daughton DM, Heatley SA, Prendergast JJ, et al. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy—a randomized, placebo-controlled, doubleblind study. Arch Intern Med. 1991;151:749–52.
Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation—six-month results from two multicenter controlled clinical trials. JAMA. 1991;266:3133–8.
Hurt RD, Dale LC, Frederickson PA, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. JAMA. 1994;271:595–600.
Fiore MC, Jorenby DE, Baker TB, Kenford SL. Tobacco dependence and the nicotine patch. JAMA. 1992;268:2687–94.
Glynn TJ, Boyd GM, Gruman JC. Essential elements of self-help/minimal intervention strategies for smoking cessation. Health Educ Q. 1990;17:329–45.
Glynn TJ, Boyd GM, Gruman JC. Self-Guided Strategies for Smoking Cessation: A Program Planner’s Guide. Bethesda, Md: Smoking and Tobacco Control Program, National Center Institute, USDHHS; 1990.
U.S. Dept. of Health and Human Services. The Health Consequences of Smoking: Nicotine Addiction. A Report of the Surgeon General. Washington, DC: U.S. Dept. of Health and Human Services; 1988. DHHS publication (CDC) 88–8406.
Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51:390–5.
Voorhees CC, Stillman FA, Swank RT, Heagerty PJ, Levine DM, Becker DM. Heart, body and soul: impact of church-based smoking cessation interventions on readiness to quit. Prev Med. 1996;25:277–85.
U.S. Dept. of Health and Human Services. Healthy People 2000: Midcourse Review and 1995 Revisions. Washington, DC: Government Printing Office; 1995.
Author information
Authors and Affiliations
Additional information
Supported by an American Cancer Society Career Development Award to Dr. Ahluwalia, an unrestricted grant from Marion Merrell Dow, Inc., and the Emory Medical Care Foundation.
Rights and permissions
About this article
Cite this article
Ahluwalia, J.S., Mcnagny, S.E. & Clark, W.S. Smoking cessation among inner-city African Americans unsing the nicotine transdermal patch. J GEN INTERN MED 13, 1–8 (1998). https://doi.org/10.1046/j.1525-1497.1998.00001.x
Issue Date:
DOI: https://doi.org/10.1046/j.1525-1497.1998.00001.x